MID-TERM RESULTS OF ENDOVASCULAR INTERVENTION FOR LOWER EXTREMITY ARTERY OCCLUSIVE DISEASES IN DIABETIC MELLITUS PATIENTS

Đức Tín Lê, Văn Nút Lâm

Main Article Content

Abstract

Background: Diabetes is the main factor causing lower limb vascular disease, contributing to damage to the vascular endothelium and increasing the risk of amputation [5], [9]. The group of patients with diabetes combined with occlusive disease of the lower extremities has more serious symptoms with more severe clinical manifestations such as ulcers, necrosis with infection, and sepsis. However, Vietnam still does not have many studies on the results of endovascular intervention for lower limb artery occlusion in diabetic patients, which is why we surveyed the mid-term results of this intervention. Patients with chronic lower limb arterial occlusion with diabetes. Methods: Retrospective description of case series. Results: The study had a mean age of 72.3 ± 11.2 years; Men accounted for 65.2% of the sample. Rutherford classifications 4,5 and 6 accounted for 28.1%, 40.4%, and 23.6% of the sample, respectively. Multi-level lesions with the aortic-iliac have a TASC II A rate of 76.4%; The femoropopliteal floor has a TASC II A rate of 58.4%; The below-the-knee has a TASC II B rate, accounting for 24.7% of the sample. Balloon dilatation accounts for a high proportion of all levels; the aortic-iliac accounts for 80.9%; The femoropopliteal level accounts for 52.8%, and the below-the-knee level accounts for 40.5% of the sample. The technical success rate reached 94.4%. Complications include embolism, hematoma, stent fracture, major amputation, myocardial infarction, and acute renal failure, accounting for 2.3% respectively, 2.3%, 1.1%, 1.1%, 2.3%, and 3.4% of the sample. At medium-term follow-up, the rate of head vascular circulation was 79.1%, significant major amputation was 18.6%, and stroke rate was 10.5% of the sample. Conclusion: Interventional methods to treat lower limb artery occlusion in diabetic patients have shown positive results, improved clinical symptoms, a medium-term primary patency revascularization rate, and few follow-up complications.

Article Details

References

1. Abularrage C. J., M. F. Conrad, và cs. (2010), Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions, J Vasc Surg, số 52(2), tr. 314-22.e1-4.
2. DeRubertis B. G., M. Pierce, và cs. (2008), Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia, J Vasc Surg, số 47(1), tr. 101-8.
3. Lee M. S., S. W. Rha, và cs. (2015), Comparison of diabetic and non-diabetic patients undergoing endovascular revascularization for peripheral arterial disease, J Invasive Cardiol, số 27(3), tr. 167-71.
4. Liistro F., I. Porto, và cs. (2013), Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia, Circulation, số 128 (6), tr. 615-21.
5. Mueller T., F. Hinterreiter, và cs. (2016), Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease, Vasc Med, số 21(5), tr. 445-452.
6. Lin Y, Li W, Liu W, Liu M, Li Y, Chen Y. Mid-term outcomes of endovascular treatment and risk factors for recurrence in patients with Trans-Atlantic-Inter-Society II C/D femoropopliteal lesions. Quant Imaging Med Surg. 2021 May;11(5):2028-2039.
7. Norgren L., W. R. Hiatt, và cs. (2007), Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), J Vasc Surg, số 45 Suppl S, tr. S5-67.
8. Shammas A. N., H. Jeon-Slaughter, và cs. (2017), Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus, J Endovasc Ther, số 24(3), tr. 376-382.
9. Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2015;3:105–113.
10. Xiao Liang, De-sheng Huang, và cs. (2012), Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial, Cardiovascular Diabetology, số 11, tr. 17-17.